Fed. Circ. Nixes Injunction On Mylan's Generic Doryx
The Federal Circuit on Monday vacated an injunction barring Mylan Pharmaceuticals Inc. from producing a generic version of oral antibiotic Doryx while Warner Chilcott LLC pursues a patent infringement suit over...To view the full article, register now.
Already a subscriber? Click here to view full article